These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33737516)

  • 1. Retinal ganglion cell dysfunction in preclinical Alzheimer's disease: an electrophysiologic biomarker signature.
    Asanad S; Felix CM; Fantini M; Harrington MG; Sadun AA; Karanjia R
    Sci Rep; 2021 Mar; 11(1):6344. PubMed ID: 33737516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
    Asanad S; Fantini M; Sultan W; Nassisi M; Felix CM; Wu J; Karanjia R; Ross-Cisneros FN; Sagare AP; Zlokovic BV; Chui HC; Pogoda JM; Arakaki X; Fonteh AN; Sadun AA; Harrington MG
    PLoS One; 2020; 15(5):e0232785. PubMed ID: 32469871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography.
    Cvenkel B; Sustar M; Perovšek D
    Doc Ophthalmol; 2017 Aug; 135(1):17-28. PubMed ID: 28567618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings.
    O'Bryhim BE; Apte RS; Kung N; Coble D; Van Stavern GP
    JAMA Ophthalmol; 2018 Nov; 136(11):1242-1248. PubMed ID: 30352114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing three different modes of electroretinography in experimental glaucoma: diagnostic performance and correlation to structure.
    Wilsey L; Gowrisankaran S; Cull G; Hardin C; Burgoyne CF; Fortune B
    Doc Ophthalmol; 2017 Apr; 134(2):111-128. PubMed ID: 28243926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal ganglion cell ablation in guinea pigs.
    Jnawali A; Lin X; Patel NB; Frishman LJ; Ostrin LA
    Exp Eye Res; 2021 Jan; 202():108339. PubMed ID: 33127343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
    Gomar JJ; Conejero-Goldberg C; Davies P; Goldberg TE;
    J Alzheimers Dis; 2016; 51(4):1085-97. PubMed ID: 26967213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
    J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Wang ML; Wei XE; Yu MM; Li PY; Li WB;
    Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
    Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
    J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
    J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences.
    Lombardi G; Pupi A; Bessi V; Polito C; Padiglioni S; Ferrari C; Lucidi G; Berti V; De Cristofaro MT; Piaceri I; Bagnoli S; Nacmias B; Sorbi S
    J Alzheimers Dis; 2020; 77(1):203-217. PubMed ID: 32716357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal retinal layer changes in preclinical Alzheimer's disease.
    van de Kreeke JA; Nguyen HT; Konijnenberg E; Tomassen J; den Braber A; Ten Kate M; Yaqub M; van Berckel B; Lammertsma AA; Boomsma DI; Tan HS; Visser PJ; Verbraak FD
    Acta Ophthalmol; 2021 Aug; 99(5):538-544. PubMed ID: 33073531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum biomarkers, brain volume, and retinal neuronal loss in early-onset Alzheimer's disease.
    Zhang Z; Kwapong WR; Cao L; Feng Z; Liu P; Wang R; Wu B; Zhang S
    Neurol Sci; 2024 Jun; 45(6):2615-2623. PubMed ID: 38216851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.